Literature DB >> 28122128

An 8-item short form of the Eating Disorder Examination-Questionnaire adapted for children (ChEDE-Q8).

Sören Kliem1,2, Ricarda Schmidt3, Mandy Vogel4,5, Andreas Hiemisch4,5, Wieland Kiess4,5, Anja Hilbert3.   

Abstract

Eating disturbances are common in children placing a vulnerable group of them at risk for full-syndrome eating disorders and adverse health outcomes. To provide a valid self-report assessment of eating disorder psychopathology in children, a short form of the child version of the Eating Disorder Examination (ChEDE-Q) was psychometrically evaluated. Similar to the EDE-Q, the ChEDE-Q provides assessment of eating disorder psychopathology related to anorexia nervosa, bulimia nervosa, and binge-eating disorder; however, the ChEDE-Q does not assess symptoms of avoidant/restrictive food intake disorder, pica, or rumination disorder. In 1,836 participants ages 7 to 18 years, recruited from two independent population-based samples, the factor structure of the recently established 8-item short form EDE-Q8 for adults was examined, including measurement invariance analyses on age, gender, and weight status derived from objectively measured weight and height. For convergent validity, the ChEDE-Q global score, body esteem scale, strengths and difficulties questionnaire, and sociodemographic characteristics were used. Item characteristics and age- and gender-specific norms were calculated. Confirmatory factor analysis revealed good model fit for the 8-item ChEDE-Q. Measurement invariance analyses indicated strict invariance for all analyzed subgroups. Convergent validity was provided through associations with well-established questionnaires and age, gender, and weight status, in expected directions. The newly developed ChEDE-Q8 proved to be a psychometrically sound and economical self-report assessment tool of eating disorder psychopathology in children. Further validation studies are needed, particularly concerning discriminant and predictive validity.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  ChEDE-Q; adolescence; childhood; eating disorder psychopathology; self-report assessment

Mesh:

Year:  2017        PMID: 28122128     DOI: 10.1002/eat.22658

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  5 in total

Review 1.  Children in Need-Diagnostics, Epidemiology, Treatment and Outcome of Early Onset Anorexia Nervosa.

Authors:  Beate Herpertz-Dahlmann; Brigitte Dahmen
Journal:  Nutrients       Date:  2019-08-16       Impact factor: 5.717

2.  Facilitators and barriers in anorexia nervosa treatment initiation (FABIANA): study protocol for a mixed-methods and multicentre study.

Authors:  Denise Kästner; Ines Buchholz; Angelika Weigel; Romuald Brunner; Ulrich Voderholzer; Antje Gumz; Bernd Löwe
Journal:  BJPsych Open       Date:  2019-10-21

3.  Children's Eating Attitudes Test (ChEAT): a validation study in Finnish children.

Authors:  Sohvi Lommi; Heli T Viljakainen; Elisabete Weiderpass; Rejane Augusta de Oliveira Figueiredo
Journal:  Eat Weight Disord       Date:  2019-05-22       Impact factor: 4.652

4.  Feasibility and effect of adding a concurrent parental component to a school-based wellness program using two modes of mobile-based technology - mixed methods evaluation of RCT.

Authors:  Moria Golan; Shakked Benifla; Aviv Samo; Noa Alon; Maya Mozeikov
Journal:  BMC Public Health       Date:  2022-02-14       Impact factor: 3.295

5.  Supporting families to achieve a healthy weight development for their child with overweight/obesity using the STARKIDS intervention: study protocol for a cluster-randomized controlled trial.

Authors:  Katrin Ziser; Florian Junne; Stefan Ehehalt; Katrin E Giel; Anne Herschbach; Peter Martus; Johann Jacoby; Felicitas Stuber; Zahra Rahmani Azad; Isabelle Mack; Alisa Weiland; Inga Krauß; Constanze Greule; Gorden Sudeck; Lydia Kastner; Guido Zurstiege; Andreas Hoell; Wolfgang Bethge; Torben Sammet; Olaf Schliesing; Stephan Zipfel
Journal:  Trials       Date:  2022-07-23       Impact factor: 2.728

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.